PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4300
-0.0200 (-4.44%)
At close: Mar 27, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 71.78 million as of March 27, 2026. Its market cap has increased by 5.51% in one year.
Market Cap
71.78M
Enterprise Value
71.31M
Revenue
17.60M
Ranking
n/a
PE Ratio
266.25
Stock Price
0.43
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 71.78M, an increase of 2,890.77%. That is a compound annual growth rate of 164.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 71.78M | -5.49% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Extendicare | 2.47B |
| Sienna Senior Living | 2.23B |
| Curaleaf Holdings | 2.16B |
| Green Thumb Industries | 1.86B |
| NetraMark Holdings | 81.53M |
| Zentek | 79.58M |
| ME Therapeutics Holdings | 75.12M |
| Theralase Technologies | 72.69M |